Terrie Curran Phathom Pharmaceuticals, Inc. (PHAT) insider trading activity
Terrie Curran is President and Chief Executive of Phathom Pharmaceuticals, Inc.. Currently has a direct ownership of 410,784 shares of PHAT, which is worth approximately $4.23 Million. The most recent transaction as insider was on Mar 22, 2024, when has been sold 16,851 shares (Common Stock) at a price of $9.11 per share, resulting in proceeds of $153,512. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
411K
0%
3M change
118.17%
12M change
Total Value Held
$4.23 Million
Terrie Curran Transaction History
Also insider at
TC
Terrie Curran
President and Chief Executive
Florham Park, NJ